Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis
Abstract
:1. Introduction
2. Methods
2.1. Search Strategy
2.2. Inclusion and Exclusion Criteria
2.3. Study Selection
2.4. Data Extraction
2.5. Quality Assessment
2.6. Statistical Analysis
3. Results
3.1. Study Selection and Characteristics of Included Trials
3.2. Effect of Antioxidant Lipid Supplementations on Blood Pressure
3.3. Effect of Antioxidant Lipid Supplementations on Blood Lipids
3.4. Effect of Antioxidant Lipid Supplementations on Glycemic Status
3.5. Effect of Antioxidant Lipid Supplementations among Participants with Different Cardiometabolic Health Statuses
4. Discussion
5. Study Limitations and Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Powell-Wiley, T.M.; Poirier, P.; Burke, L.E.; Després, J.-P.; Gordon-Larsen, P.; Lavie, C.J.; Lear, S.A.; Ndumele, C.E.; Neeland, I.J.; Sanders, P.; et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation 2021, 143, e984–e1010. [Google Scholar] [CrossRef] [PubMed]
- Stefan, N.; Schulze, M.B. Metabolic health and cardiometabolic risk clusters: Implications for prediction, prevention, and treatment. Lancet Diabetes Endocrinol. 2023, 11, 426–440. [Google Scholar] [CrossRef] [PubMed]
- Vo, V.; Lopez, G.; Malay, S.; Roman, Y.M. Cardiovascular Risk Factors Among Asian Americans: Perspectives on the Role of Acculturation in Cardiovascular Diseases Health Disparities. J. Immigr. Minor. Health 2024, 26, 409–420. [Google Scholar] [CrossRef]
- Rosei, C.A.; Del Pinto, R.; Grassi, G.; Muiesan, M.L.; Ferri, C. Prevalence of Cardiovascular Risk Factors and Related Medical and Lifestyle Interventions Among Italian Cardiovascular Specialists: A Proof-of-Concept Study. High Blood Press. Cardiovasc. Prev. 2023, 30, 255–264. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.X.; Zhou, Y.F.; Geng, T.; Chen, S.; Chen, S.; Wang, G.; Zhang, Y.-B.; Wang, Y.; Tu, Z.-Z.; Liu, G.; et al. Low Concordance Between Blood Pressures Measured in Periodic Health Examinations and in a Workplace-Based Hypertension Management Program. Phenomics 2022, 2, 419–429. [Google Scholar] [CrossRef] [PubMed]
- GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019, 393, 1958–1972. [Google Scholar] [CrossRef]
- García-Lluch, G.; Pardo, J.; Moreno, L.; Peña-Bautista, C.; Baquero, M.; Cháfer-Pericás, C. Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions. J. Prev. Alzheimer’s Dis. 2024, 11, 453–462. [Google Scholar] [CrossRef] [PubMed]
- Deng, X.; Wang, J.; Yu, S.; Tan, S.; Yu, T.; Xu, Q.; Chen, N.; Zhang, S.; Zhang, M.; Hu, K.; et al. Advances in the treatment of atherosclerosis with ligand-modified nanocarriers. Exploration 2023, 4, 20230090. [Google Scholar] [CrossRef] [PubMed]
- Alabdulkarim, B.; Bakeet, Z.A.N.; Arzoo, S. Role of some functional lipids in preventing diseases and promoting health. J. King Saud Univ. Sci. 2012, 24, 319–329. [Google Scholar] [CrossRef]
- Hu, Q.; Fang, Z.; Ge, J.; Li, H. Nanotechnology for cardiovascular diseases. Innovation 2022, 3, 100214. [Google Scholar] [CrossRef] [PubMed]
- Zhang, B.; Luo, W.; Cai, Y.; Liu, L.; Ma, X.; Yang, W.; Meng, S.; Zhao, G.; Sun, A.; Ge, J.; et al. Global burden of adolescent and young adult cardiovascular diseases and risk factors: Results from Global Burden of Disease Study 2019. Innov. Med. 2024, 2, 100063. [Google Scholar] [CrossRef]
- Tribble, D.L. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: Emphasison vitamin C.; vitamin E.; and beta-carotene: A statement for healthcare professionals from the American Heart Association. Circulation 1999, 99, 591–595. [Google Scholar] [CrossRef] [PubMed]
- Aune, D.; Keum, N.; Giovannucci, E.; Fadnes, L.T.; Boffetta, P.; Greenwood, D.C.; Tonstad, S.; Vatten, L.J.; Riboli, E.; Norat, T. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: A systematic review and dose-response meta-analysis of prospective studies. Am. J. Clin. Nutr. 2018, 108, 1069–1091. [Google Scholar] [CrossRef] [PubMed]
- Samimi, M.; Jamilian, M.; Asemi, Z.; Esmaillzadeh, A. Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial. Clin. Nutr. 2015, 34, 388–393. [Google Scholar] [CrossRef] [PubMed]
- Ide, K.; Koshizaka, M.; Tokuyama, H.; Tokuyama, T.; Ishikawa, T.; Maezawa, Y.; Takemoto, M.; Yokote, K. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: A pilot study. Lipids Health Dis. 2018, 17, 51. [Google Scholar] [CrossRef] [PubMed]
- Miller, E.R., 3rd; Juraschek, S.P.; Anderson, C.A.; Guallar, E.; Henoch-Ryugo, K.; Charleston, J.; Turban, S.; Bennett, M.R.; Appel, L.J. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: Results of the GO-FISH trial. Diabetes Care 2013, 36, 1462–1469. [Google Scholar] [CrossRef] [PubMed]
- Huang, Q.; Hu, Z.; Zheng, Q.; Mao, X.; Lv, W.; Wu, F.; Fu, D.; Lu, C.; Zeng, C.; Wang, F.; et al. A Proactive Intervention Study in Metabolic Syndrome High-Risk Populations Using Phenome-Based Actionable P4 Medicine Strategy. Phenomics 2024, 4, 91–108. [Google Scholar] [CrossRef] [PubMed]
- SCEND Study Collaborative Group. Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus. N. Engl. J. Med. 2018, 379, 1540–1550. [Google Scholar] [CrossRef] [PubMed]
- Limonte, C.P.; Zelnick, L.R.; Ruzinski, J.; Hoofnagle, A.N.; Thadhani, R.; Melamed, M.L.; Lee, I.-M.; Buring, J.E.; Sesso, H.D.; Manson, J.E.; et al. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: Secondary analyses from a randomised controlled trial. Diabetologia 2021, 64, 437–447. [Google Scholar] [CrossRef] [PubMed]
- McEneny, J.; Wade, L.; Young, I.S.; Masson, L.; Duthie, G.; McGinty, A.; McMaster, C.; Thies, F. Lycopene intervention reduces inflammation and improves HDL functionality in moderately overweight middle-aged individuals. J. Nutr. Biochem. 2013, 24, 163–168. [Google Scholar] [CrossRef]
- Thies, F.; Masson, L.F.; Rudd, A.; Vaughan, N.; Tsang, C.; Brittenden, J.; Simpson, W.G.; Duthie, S.; Horgan, G.W.; Duthie, G. Effect of a tomato-rich diet on markers of cardiovascular disease risk in moderately overweight, disease-free, middle-aged adults: A randomized controlled trial. Am. J. Clin. Nutr. 2012, 95, 1013–1022. [Google Scholar] [CrossRef] [PubMed]
- Saeidi, A.; Nouri-Habashi, A.; Razi, O.; Ataeinosrat, A.; Rahmani, H.; Mollabashi, S.S.; Bagherzadeh-Rahmani, B.; Aghdam, S.M.; Khalajzadeh, L.; Al Kiyumi, M.H.; et al. Astaxanthin Supplemented with High-Intensity Functional Training Decreases Adipokines Levels and Cardiovascular Risk Factors in Men with Obesity. Nutrients 2023, 15, 286. [Google Scholar] [CrossRef] [PubMed]
- Coombes, J.S.; Sharman, J.E.; Fassett, R.G. Astaxanthin has no effect on arterial stiffness, oxidative stress, or inflammation in renal transplant recipients: A randomized controlled trial (the XANTHIN trial). Am. J. Clin. Nutr. 2016, 103, 283–289. [Google Scholar] [CrossRef] [PubMed]
- Asemi, Z.; Alizadeh, S.-A.; Ahmad, K.; Goli, M.; Esmaillzadeh, A. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial. Clin. Nutr. 2016, 35, 819–825. [Google Scholar] [CrossRef] [PubMed]
- Ribaya-Mercado, J.D.; Ordovas, J.M.; Russell, R.M. Effect of beta-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women. J. Am. Coll. Nutr. 1995, 14, 614–620. [Google Scholar] [CrossRef] [PubMed]
- Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A.; The PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015, 350, g7647. [Google Scholar] [CrossRef] [PubMed]
- Riley, R.D.; Lambert, P.C.; Abo-Zaid, G. Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ 2010, 340, c221. [Google Scholar] [CrossRef] [PubMed]
- Cumpston, M.; Li, T.; Page, M.J.; Chandler, J.; Welch, V.A.; Higgins, J.P.; Thomas, J. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019, 10, Ed000142. [Google Scholar] [CrossRef] [PubMed]
- Guyatt, G.H.; Oxman, A.D.; Vist, G.E.; Kunz, R.; Falck-Ytter, Y.; Alonso-Coello, P.; Schünemann, H.J. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336, 924–926. [Google Scholar] [CrossRef]
- Appel, L.J.; Brands, M.W.; Daniels, S.R.; Karanja, N.; Elmer, P.J.; Sacks, F.M. Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Hypertension 2006, 47, 296–308. [Google Scholar] [CrossRef]
- Langsted, A.; Freiberg, J.J.; Nordestgaard, B.G. Fasting and nonfasting lipid levels: Influence of normal food intake on lipids.; lipoproteins, apolipoproteins.; and cardiovascular risk prediction. Circulation 2008, 118, 2047–2056. [Google Scholar] [CrossRef] [PubMed]
- Lenters-Westra, E.; Schindhelm, R.K.; Bilo, H.J.G.; Groenier, K.H.; Slingerland, R.J. Differences in interpretation of haemoglobin A1c values among diabetes care professionals. Neth. J. Med. 2014, 72, 462–466. [Google Scholar] [PubMed]
- Wei, M.; Gibbons, L.W.; Mitchell, T.L.; Kampert, J.B.; Stern, M.P.; Blair, S.N. Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 2000, 101, 2047–2052. [Google Scholar] [CrossRef] [PubMed]
- Chiavaroli, L.; Lee, D.; Ahmed, A.; Cheung, A.; Khan, T.A.; Mejia, S.B.; Mirrahimi, A.; Jenkins, D.J.A.; Livesey, G.; Wolever, T.M.S.; et al. Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: Systematic review and meta-analysis of randomised controlled trials. BMJ 2021, 374, n1651. [Google Scholar] [CrossRef] [PubMed]
- Higgins, J.P.; Thompson, S.G.; Deeks, J.J.; Altman, D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327, 557–560. [Google Scholar] [CrossRef] [PubMed]
- Jackson, D.; White, I.R.; Riley, R.D. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat. Med. 2012, 31, 3805–3820. [Google Scholar] [CrossRef] [PubMed]
- Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315, 629–634. [Google Scholar] [CrossRef] [PubMed]
- Tobias, A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 1998, 47, 15–17. [Google Scholar]
- Yu, Q.; Liu, Y.; Wu, Y.; Chen, Y. Dihydrocurcumin ameliorates the lipid accumulation.; oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells. Biomed. Pharmacother. 2018, 103, 1327–1336. [Google Scholar] [CrossRef] [PubMed]
- Zhang, H.; Wang, J.; Yang, L.; Yang, W.; Luo, T.; Yuan, Y.; Gu, J.; Zou, H.; Bian, J.; Liu, Z.; et al. Effect of oleic acid on induction of steatosis and cytotoxicity in BRL 3A cells. J. Cell. Biochem. 2019, 120, 19541–19554. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.P.S.; Dart, A.M.; Walker, K.Z.; O’Dea, K.; Chin-Dusting, J.P.F.; Skilton, M.R. Effect of altering dietary n-6:n-3 PUFA ratio on cardiovascular risk measures in patients treated with statins: A pilot study. Br. J. Nutr. 2012, 108, 1280–1285. [Google Scholar] [CrossRef] [PubMed]
- Gnoni, A.; Giudetti, A.M. Dietary long-chain unsaturated fatty acids acutely and differently reduce the activities of lipogenic enzymes and of citrate carrier in rat liver. J. Physiol. Biochem. 2016, 72, 485–494. [Google Scholar] [CrossRef] [PubMed]
- Tang, M.; Floyd, S.; Cai, H.; Zhang, M.; Yang, R.; Dang, R. The status of ω-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway. Food Funct. 2019, 10, 4649–4660. [Google Scholar] [CrossRef] [PubMed]
- Froyen, E.; Burns-Whitmore, B. The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease in Healthy Individuals: A Review of Human Intervention Trials. Nutrients 2020, 12, 2329. [Google Scholar] [CrossRef] [PubMed]
- An, P.; Wan, S.; Luo, Y.; Luo, J.; Zhang, X.; Zhou, S.; Xu, T.; He, J.; Mechanick, J.I.; Wu, W.-C.; et al. Micronutrient Supplementation to Reduce Cardiovascular Risk. J. Am. Coll. Cardiol. 2022, 80, 2269–2285. [Google Scholar] [CrossRef]
- Gajendragadkar, P.R.; Hubsch, A.; Mäki-Petäjä, K.M.; Serg, M.; Wilkinson, I.B.; Cheriyan, J. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: A randomised controlled trial. PLoS ONE 2014, 9, e99070. [Google Scholar] [CrossRef] [PubMed]
- Wolak, T.; Sharoni, Y.; Levy, J.; Linnewiel-Hermoni, K.; Stepensky, D.; Paran, E. Effect of Tomato Nutrient Complex on Blood Pressure: A Double Blind, Randomized Dose-Response Study. Nutrients 2019, 11, 950. [Google Scholar] [CrossRef] [PubMed]
- Umans, J.G.; Levi, R. Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 1995, 57, 771–790. [Google Scholar] [CrossRef]
- Förstermann, U.; Sessa, W.C. Nitric oxide synthases: Regulation and function. Eur. Heart J. 2012, 33, 829–837. [Google Scholar] [CrossRef] [PubMed]
- Urakaze, M.; Kobashi, C.; Satou, Y.; Shigeta, K.; Toshima, M.; Takagi, M.; Takahashi, J.; Nishida, H. The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes. Nutrients 2021, 13, 4381. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.; Seo, J.M.; Nguyen, A.; Pham, T.X.; Park, H.J.; Park, Y.; Kim, B.; Bruno, R.S.; Lee, J. Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J. Nutr. 2011, 141, 1611–1617. [Google Scholar] [CrossRef] [PubMed]
- Bhuvaneswari, S.; Anuradha, C.V. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can. J. Physiol. Pharmacol. 2012, 90, 1544–1552. [Google Scholar] [CrossRef] [PubMed]
- Ishiki, M.; Nishida, Y.; Ishibashi, H.; Wada, T.; Fujisaka, S.; Takikawa, A.; Urakaze, M.; Sasaoka, T.; Usui, I.; Tobe, K. Impact of divergent effects of astaxanthin on insulin signaling in L6 cells. Endocrinology 2013, 154, 2600–2612. [Google Scholar] [CrossRef] [PubMed]
- Chen, Q.H.; Wu, B.K.; Pan, D.; Sang, L.X.; Chang, B. Beta-carotene and its protective effect on gastric cancer. World J. Clin. Cases 2021, 9, 6591–6607. [Google Scholar] [CrossRef] [PubMed]
- Palozza, P. Prooxidant actions of carotenoids in biologic systems. Nutr. Rev. 1998, 56, 257–265. [Google Scholar] [CrossRef] [PubMed]
- Truscott, T.G. Beta-carotene and disease: A suggested pro-oxidant and anti-oxidant mechanism and speculations concerning its role in cigarette smoking. J. Photochem. Photobiol. B 1996, 35, 233–235. [Google Scholar] [CrossRef] [PubMed]
- Gormaz, J.G.; Carrasco, R. Antioxidant Supplementation in Cardiovascular Prevention: New Challenges in the Face of New Evidence. J. Am. Coll. Cardiol. 2022, 80, 2286–2288. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Wan, S.; Wu, W.; Zhang, Y.; He, J.; Wang, X.; An, P.; Luo, J.; Zhu, Y.; Luo, Y. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Nutrients 2024, 16, 2213. https://doi.org/10.3390/nu16142213
Wan S, Wu W, Zhang Y, He J, Wang X, An P, Luo J, Zhu Y, Luo Y. Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis. Nutrients. 2024; 16(14):2213. https://doi.org/10.3390/nu16142213
Chicago/Turabian StyleWan, Sitong, Wenbin Wu, Yan Zhang, Jian He, Xiaoping Wang, Peng An, Junjie Luo, Yinhua Zhu, and Yongting Luo. 2024. "Antioxidant Lipid Supplement on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis" Nutrients 16, no. 14: 2213. https://doi.org/10.3390/nu16142213